Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2025-12-27 @ 3:36 AM
Study NCT ID:
NCT00688467
Status:
COMPLETED
Last Update Posted:
2019-01-02
First Post:
2008-05-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Navarixin (SCH 527123) in Participants With Allergen-Induced Asthma (P05363)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2009-03-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-03-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-05-29
First Submit QC Date:
None
Study First Post Date:
2008-06-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-09-26
Results First Submit QC Date:
None
Results First Post Date:
2014-10-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-12-10
Last Update Post Date:
2019-01-02
Last Update Post Date Type:
ACTUAL